Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users

NCT07571148 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

6876

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: KarXT (xanomeline and trospium)

Sponsor

Bristol-Myers Squibb